89 related articles for article (PubMed ID: 28088330)
1. Targeted therapy for gynecologic cancers: Toward the era of precision medicine.
Basu P; Mukhopadhyay A; Konishi I
Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():131-136. PubMed ID: 30306576
[TBL] [Abstract][Full Text] [Related]
2. Moving Toward Personalized Medicine in Gynecologic Cancers.
Ludwig M; Taunk N; Chino J; Hathout L; Leung E; Fields E
Int J Radiat Oncol Biol Phys; 2024 May; 119(1):1-5. PubMed ID: 38631739
[No Abstract] [Full Text] [Related]
3. Comprehensive Approach to Genomic and Immune Profiling: Insights of a Real-World Experience in Gynecological Tumors.
Prieto-Potin I; Idrovo F; Suárez-Gauthier A; Díaz-Blázquez M; Astilleros-Blanco de Córdova L; Chamizo C; Zazo S; Carvajal N; López-Sánchez A; Pérez-Buira S; Aúz-Alexandre CL; Manso R; Plaza-Sánchez J; de Lucas-López V; Pérez-González N; Martín-Valle S; Cristóbal I; Casado V; García-Foncillas J; Rojo F
Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010253
[TBL] [Abstract][Full Text] [Related]
4. TPX2 Serves as a Cancer Susceptibility Gene and Is Closely Associated with the Poor Prognosis of Endometrial Cancer.
Wang J; Zheng H; He H; Meng S; Han Y; Su Z; Yan H; Zhang Y
Genet Res (Camb); 2022; 2022():5401106. PubMed ID: 35356748
[TBL] [Abstract][Full Text] [Related]
5. Machine Learning for Recurrence Prediction of Gynecologic Cancers Using Lynch Syndrome-Related Screening Markers.
Kim BW; Choi MC; Kim MK; Lee JW; Kim MT; Noh JJ; Park H; Jung SG; Joo WD; Song SH; Lee C
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830824
[TBL] [Abstract][Full Text] [Related]
6. m
Zhai J; Li S; Sen S; Opoku-Anane J; Du Y; Chen ZJ; Giudice LC
Front Genet; 2020; 11():716. PubMed ID: 32719721
[TBL] [Abstract][Full Text] [Related]
7. Detection of high-risk human papillomavirus DNA in tissue from primary cervical cancer tumor, pelvic lymph nodes and recurrent disease.
Fuglsang K; Blaakaer J; Petersen LK; Mejlgaard E; Hammer A; Steiniche T
Papillomavirus Res; 2019 Jun; 7():15-20. PubMed ID: 30557633
[TBL] [Abstract][Full Text] [Related]
8. Genomic profiling of gynecologic cancers and implications for clinical practice.
Prendergast EN; Elvin JA
Curr Opin Obstet Gynecol; 2017 Feb; 29(1):18-25. PubMed ID: 27984344
[TBL] [Abstract][Full Text] [Related]
9. Genomic insights in gynecologic cancer.
Roddy E; Chapman J
Curr Probl Cancer; 2017; 41(1):8-36. PubMed ID: 28088330
[TBL] [Abstract][Full Text] [Related]
10. Rational selection of biomarker driven therapies for gynecologic cancers: The more we know, the more we know we don't know.
Liu J; Westin SN
Gynecol Oncol; 2016 Apr; 141(1):65-71. PubMed ID: 27016231
[TBL] [Abstract][Full Text] [Related]
11. Moving From Mutation to Actionability.
Colombo I; Kurnit KC; Westin SN; Oza AM
Am Soc Clin Oncol Educ Book; 2018 May; 38():495-503. PubMed ID: 30231353
[TBL] [Abstract][Full Text] [Related]
12. Genomic-Based Therapy of Gynecologic Malignancies.
Markman M
Acta Med Acad; 2019 Apr; 48(1):84-89. PubMed ID: 31264436
[TBL] [Abstract][Full Text] [Related]
13. Use of comprehensive genomic profiling to direct point-of-care management of patients with gynecologic cancers.
Rodriguez-Rodriguez L; Hirshfield KM; Rojas V; DiPaola RS; Gibbon D; Hellmann M; Isani S; Leiser A; Riedlinger GM; Wagreich A; Ali SM; Elvin JA; Miller VA; Ganesan S
Gynecol Oncol; 2016 Apr; 141(1):2-9. PubMed ID: 27016222
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
